Segment Information (Tables)

3 Months Ended

Jun. 30, 2012

Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:



	Quarter Ended June 30,
(In millions)	2012			2011
Revenues
Distribution Solutions ⁽¹⁾
Direct distribution & services	$	21,301		$	20,827
Sales to customers’ warehouses	5,347			4,891
Total U.S. pharmaceutical distribution & services	26,648			25,718
Canada pharmaceutical distribution & services	2,517			2,729
Medical-Surgical distribution & services	795			731
Total Distribution Solutions	29,960			29,178
Technology Solutions
Services	666			630
Software & software systems	145			144
Hardware	27			28
Total Technology Solutions	838			802
Total Revenues	$	30,798		$	29,980

Operating profit
Distribution Solutions ⁽²⁾	$	500		$	475
Technology Solutions	93			100
Total	593			575
Corporate Expenses, Net ⁽³⁾	(6		)	(95		)
Interest Expense	(56		)	(64		)
Income Before Income Taxes	$	531		$	416


⁽¹⁾	Revenues derived from services represent less than 2% of this segment’s total revenues.


⁽²⁾	Operating profit for the first quarter of 2013 includes an AWP litigation charge of $16 million, which was recorded in operating expenses.


⁽³⁾	Corporate expenses for the first quarter of 2013 are net of an $81 million gain on business combination.

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details